ES2095847T3 - Desnaturalizacion oxidativa de analitos proteicos. - Google Patents

Desnaturalizacion oxidativa de analitos proteicos.

Info

Publication number
ES2095847T3
ES2095847T3 ES90112199T ES90112199T ES2095847T3 ES 2095847 T3 ES2095847 T3 ES 2095847T3 ES 90112199 T ES90112199 T ES 90112199T ES 90112199 T ES90112199 T ES 90112199T ES 2095847 T3 ES2095847 T3 ES 2095847T3
Authority
ES
Spain
Prior art keywords
protein
analyts
denaturalization
oxidative
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90112199T
Other languages
English (en)
Inventor
James Elting
Heinz Kolbl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of ES2095847T3 publication Critical patent/ES2095847T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57565—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen [CEA]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

UN METODO PARA CONFERIR ANTIGENICIDAD O INCREMENTAR ESTA EN UNA PROTEINA ENLAZADA CON DISULFURO, TRATANDO LA PROTEINA CON UN AGENTE OXIDANTE, POR EJEMPLO UN PERIODATO, CON UN POTENCIAL DE OXIDACION SUFICIENTE PARA PENETRAR LOS ENLACES DEL DISULFURO. DESPUES SE INACTIVA EL EXCESO DE AGENTE OXIDANTE AÑADIENDO UN AGENTE REDUCTOR. LA PROTEINA RESULTANTE EXHIBE UN INCREMENTO DE SU CAPACIDAD DE LIGARSE CON ANTICUERPOS SELECCIONADOS, EN PARTICULAR, ANTICUERPOS MONOCLONALES DIRIGIDOS A LOS EPITOPES PEPTIDOS LINEALES DE LA PROTEINA.
ES90112199T 1989-07-10 1990-07-06 Desnaturalizacion oxidativa de analitos proteicos. Expired - Lifetime ES2095847T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/377,680 US5061790A (en) 1989-07-10 1989-07-10 Oxidative denaturation of protein analytes

Publications (1)

Publication Number Publication Date
ES2095847T3 true ES2095847T3 (es) 1997-03-01

Family

ID=23490110

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90112199T Expired - Lifetime ES2095847T3 (es) 1989-07-10 1990-07-06 Desnaturalizacion oxidativa de analitos proteicos.

Country Status (18)

Country Link
US (1) US5061790A (es)
EP (1) EP0407813B1 (es)
JP (1) JP2915970B2 (es)
KR (1) KR910003380A (es)
AT (1) ATE147167T1 (es)
AU (1) AU633115B2 (es)
CA (1) CA2019671C (es)
DE (1) DE69029540T2 (es)
DK (1) DK0407813T3 (es)
ES (1) ES2095847T3 (es)
FI (1) FI903464A7 (es)
GR (1) GR3022906T3 (es)
IE (1) IE902493A1 (es)
IL (1) IL94993A (es)
NO (1) NO902833L (es)
NZ (1) NZ234396A (es)
PT (1) PT94633B (es)
ZA (1) ZA905360B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740223B1 (fr) * 1995-10-19 1997-11-14 Commissariat Energie Atomique Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
AU1951001A (en) * 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
WO2003002908A1 (en) * 2000-06-26 2003-01-09 Reveo, Inc. Backlight for a liquid crystal display having high light-recycling efficiency
DE10054055A1 (de) * 2000-10-31 2002-05-23 Nmi Univ Tuebingen Verfahren zur Analyse von Proteinen
US7618788B2 (en) * 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US7460960B2 (en) * 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
AU2004248155B2 (en) 2003-06-09 2008-10-23 Redox-Reactive Reagents L.L.C. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
US9557325B2 (en) * 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
US7892751B2 (en) * 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
JP5081930B2 (ja) * 2007-03-08 2012-11-28 エフ．ホフマン−ラ ロシュ アーゲー 心不全の評価におけるｓｌｉｍ−１の使用
KR101322247B1 (ko) * 2007-09-06 2013-10-25 삼성전자주식회사 진공청소기용 흡입브러시 및 그 높이조절방법
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
US20130189707A1 (en) * 2010-01-26 2013-07-25 Svetlana Alexandrovna Sergeeva Method of determination of autoantibody level by means of enzyme immunoassay
KR20140137353A (ko) * 2012-02-02 2014-12-02 퍼피니티 바이오사이언시즈, 인코포레이티드 단일 분석에서의 다중 분석물을 위한 선별제 기반 인식 및 정량 시스템 및 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448530C3 (de) * 1974-10-11 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Derivaten des Diphtherietoxins und diese enthaltende Mittel
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides

Also Published As

Publication number Publication date
EP0407813A3 (en) 1992-11-25
NO902833L (no) 1991-01-11
IL94993A0 (en) 1991-06-10
DE69029540T2 (de) 1997-05-07
KR910003380A (ko) 1991-02-27
JP2915970B2 (ja) 1999-07-05
AU5872790A (en) 1991-01-10
PT94633A (pt) 1991-03-20
EP0407813A2 (en) 1991-01-16
EP0407813B1 (en) 1997-01-02
CA2019671A1 (en) 1991-01-10
IE902493A1 (en) 1991-02-13
JPH0368868A (ja) 1991-03-25
IL94993A (en) 1994-05-30
CA2019671C (en) 2002-08-13
PT94633B (pt) 1997-04-30
NO902833D0 (no) 1990-06-26
US5061790A (en) 1991-10-29
DE69029540D1 (de) 1997-02-13
FI903464A0 (fi) 1990-07-09
GR3022906T3 (en) 1997-06-30
NZ234396A (en) 1992-02-25
AU633115B2 (en) 1993-01-21
ZA905360B (en) 1991-04-24
DK0407813T3 (da) 1997-06-16
ATE147167T1 (de) 1997-01-15
FI903464A7 (fi) 1991-01-11

Similar Documents

Publication Publication Date Title
ES2095847T3 (es) Desnaturalizacion oxidativa de analitos proteicos.
ES2076142T3 (es) Peptidos para el diagnostico de anticuerpos para htlv-iii, su preparacion y uso.
SE7705432L (sv) Polypeptid och sett for dess framstellning
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
ES2126145T3 (es) Redireccionamiento de anticuerpos.
DK0610286T3 (da) Rekombinante immunotoxiner
ES2530510T3 (es) Constructos peptídicos sintéticos para el diagnóstico y tratamiento de periodontitis asociada con Porphyromonas gingivalis
ES2169080T3 (es) Inhibidor de la agregacion de plaquetas estimulada por colageno.
DK0684816T3 (da) 5-HT2-receptorantagonister til behandling af venöse tilstande
ES524060A0 (es) Procedimiento para la preparacion de un agente para el tratamiento de heridas
ES2061744T3 (es) Inmunogeno y su aplicacion para la obtencion de anticuerpos especificos contra hba1c.
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
FR2253494B1 (es)
ES8800981A1 (es) Un procedimiento para tratar celulas efectoras que tienen receptores de superficie para la region fc de un anticuerpo
ES2136724T3 (es) Emulsion liofilizada, que contiene una sustancia activa.
ES2074591T3 (es) Expresion de polipeptidos de vih 1 y 2 y su utilizacion.
ES2099820T3 (es) Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos.
ES2089105T3 (es) Agente modificador del cuero, procedimiento para modificarlo y cuero curtido asi modificado.
ES2000615A6 (es) Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3"
ES2082017T3 (es) Anticuerpo monoclonal que reconoce el epitopo especifico de glucosidos de antraciclina e hibridoma que secreta dicho anticuerpo.
NL191918C (nl) Conferentieverbindingsketen.
SE7713700L (sv) 2-substituerade-1-(omega-aminoalkoxi)bensener
ATE107696T1 (de) Cdns kodierend für somatotropin, expressionsvektoren und -wirte.
ES2039250T3 (es) Tratamiento de materiales de lana.
ES2125442T3 (es) Extraccion de proteina celular de bordetella.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 407813

Country of ref document: ES